Cargando…

Heterogeneous patterns of DNA methylation-based field effects in histologically normal prostate tissue from cancer patients

Prostate cancer (PC) diagnosis is based on histological evaluation of prostate needle biopsies, which have high false negative rates. Here, we investigated if cancer-associated epigenetic field effects in histologically normal prostate tissue may be used to increase sensitivity for PC. We focused on...

Descripción completa

Detalles Bibliográficos
Autores principales:	Møller, Mia, Strand, Siri Hundtofte, Mundbjerg, Kamilla, Liang, Gangning, Gill, Inderbir, Haldrup, Christa, Borre, Michael, Høyer, Søren, Ørntoft, Torben Falck, Sørensen, Karina Dalsgaard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5233981/ https://www.ncbi.nlm.nih.gov/pubmed/28084441 http://dx.doi.org/10.1038/srep40636

Ejemplares similares

Exploring the transcriptome of hormone-naive multifocal prostate cancer and matched lymph node metastases
por: Schmidt, Linnéa, et al.
Publicado: (2018)

Biomarker potential of ST6GALNAC3 and ZNF660 promoter hypermethylation in prostate cancer tissue and liquid biopsies
por: Haldrup, Christa, et al.
Publicado: (2018)

epiG: statistical inference and profiling of DNA methylation from whole-genome bisulfite sequencing data
por: Vincent, Martin, et al.
Publicado: (2017)

Comprehensive Evaluation of TFF3 Promoter Hypomethylation and Molecular Biomarker Potential for Prostate Cancer Diagnosis and Prognosis
por: Nørgaard, Maibritt, et al.
Publicado: (2017)

High levels of 5-hydroxymethylcytosine (5hmC) is an adverse predictor of biochemical recurrence after prostatectomy in ERG-negative prostate cancer
por: Strand, Siri H., et al.
Publicado: (2015)

Novel diagnostic and prognostic classifiers for prostate cancer identified by genome-wide microRNA profiling
por: Kristensen, Helle, et al.
Publicado: (2016)

High miR-449b expression in prostate cancer is associated with biochemical recurrence after radical prostatectomy
por: Mortensen, Martin Mørck, et al.
Publicado: (2014)

RHCG and TCAF1 promoter hypermethylation predicts biochemical recurrence in prostate cancer patients treated by radical prostatectomy
por: Strand, Siri H., et al.
Publicado: (2016)

Expression profiling of prostate cancer tissue delineates genes associated with recurrence after prostatectomy
por: Mortensen, Martin Mørck, et al.
Publicado: (2015)

Dysregulation and prognostic potential of 5-methylcytosine (5mC), 5-hydroxymethylcytosine (5hmC), 5-formylcytosine (5fC), and 5-carboxylcytosine (5caC) levels in prostate cancer
por: Storebjerg, Tine Maj, et al.
Publicado: (2018)

Perceptions about screening for prostate cancer using genetic lifetime risk assessment: a qualitative study
por: Kirkegaard, Pia, et al.
Publicado: (2018)

Epigenetic silencing of MEIS2 in prostate cancer recurrence
por: Nørgaard, Maibritt, et al.
Publicado: (2019)

Prognostic DNA Methylation Markers for Prostate Cancer
por: Strand, Siri H., et al.
Publicado: (2014)

Prognostic significance of aberrantly silenced ANPEP expression in prostate cancer
por: Sørensen, K D, et al.
Publicado: (2013)

Identifying aggressive prostate cancer foci using a DNA methylation classifier
por: Mundbjerg, Kamilla, et al.
Publicado: (2017)

5hmC Level Predicts Biochemical Failure Following Radical Prostatectomy in Prostate Cancer Patients with ERG Negative Tumors
por: Kristensen, Gitte, et al.
Publicado: (2019)

An Optimized Shotgun Strategy for the Rapid Generation of Comprehensive Human Proteomes
por: Bekker-Jensen, Dorte B., et al.
Publicado: (2017)

Aberrant DOCK2, GRASP, HIF3A and PKFP Hypermethylation has Potential as a Prognostic Biomarker for Prostate Cancer
por: Bjerre, Marianne T., et al.
Publicado: (2019)

Training and validation of a novel 4-miRNA ratio model (MiCaP) for prediction of postoperative outcome in prostate cancer patients
por: Schmidt, L, et al.
Publicado: (2018)

Investigation of enzalutamide, docetaxel, and cabazitaxel resistance in the castration resistant prostate cancer cell line C4 using genome-wide CRISPR/Cas9 screening
por: Haldrup, Jakob, et al.
Publicado: (2023)

Comprehensive multiregional analysis of molecular heterogeneity in bladder cancer
por: Thomsen, Mathilde Borg Houlberg, et al.
Publicado: (2017)

Chromosomal imbalance in the progression of high-risk non-muscle invasive bladder cancer
por: Zieger, Karsten, et al.
Publicado: (2009)

Outlining the limits of partial nephrectomy
por: Chopra, Sameer, et al.
Publicado: (2015)

Next-Generation Sequencing of RNA and DNA Isolated from Paired Fresh-Frozen and Formalin-Fixed Paraffin-Embedded Samples of Human Cancer and Normal Tissue
por: Hedegaard, Jakob, et al.
Publicado: (2014)

Validation of the four-miRNA biomarker panel MiCaP for prediction of long-term prostate cancer outcome
por: Strand, Siri H., et al.
Publicado: (2020)

Microbiota of the prostate tumor environment investigated by whole-transcriptome profiling
por: Salachan, Paul Vinu, et al.
Publicado: (2022)

Diagnosis of Bladder Cancer Recurrence Based on Urinary Levels of EOMES, HOXA9, POU4F2, TWIST1, VIM, and ZNF154 Hypermethylation
por: Reinert, Thomas, et al.
Publicado: (2012)

High expression of GEM and EDNRA is associated with metastasis and poor outcome in patients with advanced bladder cancer
por: Laurberg, Jens Reumert, et al.
Publicado: (2014)

Genome-wide analysis of allelic imbalance in prostate cancer using the Affymetrix 50K SNP mapping array
por: Tørring, N, et al.
Publicado: (2007)

Bioinformatic identification of FGF, p38-MAPK, and calcium signalling pathways associated with carcinoma in situ in the urinary bladder
por: Herbsleb, Malene, et al.
Publicado: (2008)

Identification of expressed and conserved human noncoding RNAs
por: Nielsen, Morten Muhlig, et al.
Publicado: (2014)

Unsupervised detection of fragment length signatures of circulating tumor DNA using non-negative matrix factorization
por: Renaud, Gabriel, et al.
Publicado: (2022)

Danish Prostate Cancer Consortium Study 1 (DPCC-1) protocol: Multicentre prospective validation of the urine-based three-microRNA biomarker model uCaP
por: Fredsøe, Jacob, et al.
Publicado: (2023)

A lack of financial planning predicts increased mortality risk: Evidence from cohort studies in the United Kingdom and United States
por: Gladstone, Joe J., et al.
Publicado: (2023)

Widespread DNA hypomethylation and differential gene expression in Turner syndrome
por: Trolle, Christian, et al.
Publicado: (2016)

Evaluation of Predictors of Biochemical Recurrence in Prostate Cancer Patients, as Detected by (68)Ga-PSMA PET/CT
por: Christensen, Mads T., et al.
Publicado: (2022)

Prostate Cancer Detection Rate of Manually Operated and Robot-assisted In-bore Magnetic Resonance Imaging Targeted Biopsy
por: Sandahl, Mads, et al.
Publicado: (2022)

Identification of a high-risk immunogenic prostate cancer patient subset as candidates for T-cell engager immunotherapy and the introduction of a novel albumin-fused anti-CD3 × anti-PSMA bispecific design
por: Glud, Eske N., et al.
Publicado: (2022)

High frequency of tumor cells with nuclear Egr-1 protein expression in human bladder cancer is associated with disease progression
por: Egerod, Frederikke Lihme, et al.
Publicado: (2009)

Keratin23 (KRT23) Knockdown Decreases Proliferation and Affects the DNA Damage Response of Colon Cancer Cells
por: Birkenkamp-Demtröder, Karin, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_bfco460518g918r7kk3u4s7qr9